The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Stream Infection Testing-Global Market Insights and Sales Trends 2024
Synopsis
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
The global Blood Stream Infection Testing market size is expected to reach US$ 5862.7 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Stream Infection Testing in various end use industries. The expanding demands from the Hospitals, Independent Diagnostic Centers and Others,, are propelling Blood Stream Infection Testing market. Conventional Blood Culture Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR Methods segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Stream Infection Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Stream Infection Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Stream Infection Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Stream Infection Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Stream Infection Testing covered in this report include BD, bioMérieux, Cepheid, Roche Diagnostics, IRIDICA, Bruker, Nanosphere, Siemens and AdvanDX, etc.
The global Blood Stream Infection Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Global Blood Stream Infection Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Stream Infection Testing market, Segment by Type:
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Global Blood Stream Infection Testing market, by Application
Hospitals
Independent Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Stream Infection Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
The global Blood Stream Infection Testing market size is expected to reach US$ 5862.7 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Stream Infection Testing in various end use industries. The expanding demands from the Hospitals, Independent Diagnostic Centers and Others,, are propelling Blood Stream Infection Testing market. Conventional Blood Culture Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR Methods segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Stream Infection Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Stream Infection Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Stream Infection Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Stream Infection Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Stream Infection Testing covered in this report include BD, bioMérieux, Cepheid, Roche Diagnostics, IRIDICA, Bruker, Nanosphere, Siemens and AdvanDX, etc.
The global Blood Stream Infection Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Global Blood Stream Infection Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Stream Infection Testing market, Segment by Type:
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Global Blood Stream Infection Testing market, by Application
Hospitals
Independent Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Stream Infection Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Blood Stream Infection Testing
1.1 Blood Stream Infection Testing Market Overview
1.1.1 Blood Stream Infection Testing Product Scope
1.1.2 Blood Stream Infection Testing Market Status and Outlook
1.2 Global Blood Stream Infection Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Blood Stream Infection Testing Market Size by Region (2018-2029)
1.4 Global Blood Stream Infection Testing Historic Market Size by Region (2018-2023)
1.5 Global Blood Stream Infection Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Blood Stream Infection Testing Market Size (2018-2029)
1.6.1 North America Blood Stream Infection Testing Market Size (2018-2029)
1.6.2 Europe Blood Stream Infection Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Blood Stream Infection Testing Market Size (2018-2029)
1.6.4 Latin America Blood Stream Infection Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Blood Stream Infection Testing Market Size (2018-2029)
2 Blood Stream Infection Testing Market by Type
2.1 Introduction
2.1.1 Conventional Blood Culture Tests
2.1.2 PCR Methods
2.1.3 Nucleic Acid Testing
2.1.4 Mass Spectroscopy
2.1.5 Point of Care Testing
2.2 Global Blood Stream Infection Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Blood Stream Infection Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Blood Stream Infection Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Blood Stream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Blood Stream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Blood Stream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Blood Stream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Blood Stream Infection Testing Revenue Breakdown by Type (2018-2029)
3 Blood Stream Infection Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Independent Diagnostic Centers
3.1.3 Others
3.2 Global Blood Stream Infection Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Blood Stream Infection Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Blood Stream Infection Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Blood Stream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Blood Stream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Blood Stream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Blood Stream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Blood Stream Infection Testing Revenue Breakdown by Application (2018-2029)
4 Blood Stream Infection Testing Competition Analysis by Players
4.1 Global Blood Stream Infection Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Stream Infection Testing as of 2022)
4.3 Date of Key Players Enter into Blood Stream Infection Testing Market
4.4 Global Top Players Blood Stream Infection Testing Headquarters and Area Served
4.5 Key Players Blood Stream Infection Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Stream Infection Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BD
5.1.1 BD Profile
5.1.2 BD Main Business
5.1.3 BD Blood Stream Infection Testing Products, Services and Solutions
5.1.4 BD Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.1.5 BD Recent Developments
5.2 bioMérieux
5.2.1 bioMérieux Profile
5.2.2 bioMérieux Main Business
5.2.3 bioMérieux Blood Stream Infection Testing Products, Services and Solutions
5.2.4 bioMérieux Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.2.5 bioMérieux Recent Developments
5.3 Cepheid
5.3.1 Cepheid Profile
5.3.2 Cepheid Main Business
5.3.3 Cepheid Blood Stream Infection Testing Products, Services and Solutions
5.3.4 Cepheid Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostics Recent Developments
5.4 Roche Diagnostics
5.4.1 Roche Diagnostics Profile
5.4.2 Roche Diagnostics Main Business
5.4.3 Roche Diagnostics Blood Stream Infection Testing Products, Services and Solutions
5.4.4 Roche Diagnostics Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostics Recent Developments
5.5 IRIDICA
5.5.1 IRIDICA Profile
5.5.2 IRIDICA Main Business
5.5.3 IRIDICA Blood Stream Infection Testing Products, Services and Solutions
5.5.4 IRIDICA Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.5.5 IRIDICA Recent Developments
5.6 Bruker
5.6.1 Bruker Profile
5.6.2 Bruker Main Business
5.6.3 Bruker Blood Stream Infection Testing Products, Services and Solutions
5.6.4 Bruker Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Bruker Recent Developments
5.7 Nanosphere
5.7.1 Nanosphere Profile
5.7.2 Nanosphere Main Business
5.7.3 Nanosphere Blood Stream Infection Testing Products, Services and Solutions
5.7.4 Nanosphere Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Nanosphere Recent Developments
5.8 Siemens
5.8.1 Siemens Profile
5.8.2 Siemens Main Business
5.8.3 Siemens Blood Stream Infection Testing Products, Services and Solutions
5.8.4 Siemens Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Recent Developments
5.9 AdvanDX
5.9.1 AdvanDX Profile
5.9.2 AdvanDX Main Business
5.9.3 AdvanDX Blood Stream Infection Testing Products, Services and Solutions
5.9.4 AdvanDX Blood Stream Infection Testing Revenue (US$ Million) & (2018-2023)
5.9.5 AdvanDX Recent Developments
6 North America
6.1 North America Blood Stream Infection Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Blood Stream Infection Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Stream Infection Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Stream Infection Testing Market Dynamics
11.1 Blood Stream Infection Testing Industry Trends
11.2 Blood Stream Infection Testing Market Drivers
11.3 Blood Stream Infection Testing Market Challenges
11.4 Blood Stream Infection Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
